The Academic Urology Group was established in Cambridge in 2014. The primary research focus of the group is in uro-oncology and in particular prostate and renal cancer. The group has an outstanding record of publications both in basic science and translational research. A strong theme of the AUG is close integration of research into clinical practice with the aim of improving early cancer detection, prognostic stratification and primary therapy outcomes from patients treated for urological cancers. The overarching ethos of the group is to develop and progress research that is based on close collaborative multi-disciplinary working with colleagues in radiology, pathology, basic sciences, oncology and epidemiology. In addition, the AUG works closely with clinical colleagues in the Department of Urology which is renowned for its world class clinical urological service. The AUG are major participants of the CRUK Cambridge Cancer Centre Urological Malignancies Programme.
Academic training programme
The AUG has a vibrant programme for academic trainees and has been very successful in attracting local and national funding for ACF and ACL. Academic trainees are supervised by one of the 2 lead university lecturers in the AUG. The programme benefits greatly from close working with the East of England urology training programme. This has led to all 6 former ACF successfully completing higher degrees and attaining CCT as well as three progressing to clinical lecturer positions and 2 to clinician scientist appointments. There are currently 3 at various stages of training and a new ACL appointment planned. We would be pleased to hear from prospective candidates for our next intake of urology fellows. Please email Mr Vincent Gnanapragasam.
Cambridge Urology Translational Research and Clinical Trials Office (CUTRACT)
The Cambridge urology clinical trials team was initiated in 2011 with the primary goal of building up the local NIHR and commercial urology trials portfolio within the Department of Urology. In 2014 the Cambridge Urology Translational Research and Clinical Trials (CUTRACT) office was established in its own premises (directed by Mr Vincent J Gnanapragasam) with the aim of consolidating the diverse research undertaken in urology in Cambridge. CUTRACT has been highly successful, bringing in over £2.0M in research funding and recruitment of over 1200 patients into a diverse range of studies. CUTRACT has also initiated a number of investigator-led trials within the team in addition to this portfolio. In the last 3 years CUTRACT has successfully led, conducted and completed 3 multi-center trials recruiting >700 patients. The CUTRACT team would be very pleased to hear from academic NIHR or commercial partners who would like to explore urological research trials in Cambridge. Please email Mr Vincent J Gnanapragasam or Sister Kelly Leonard or call 01223 348442.
Prostate and renal cancer academic research programmes
AUG prostate and renal cancer research is led by Mr VJ Gnanapragasam and Professor Grant Stewart respectively and both are closely linked with the wider CRUK Cambridge Cancer Centre Urological Malignancies programme. Mr Tom Mitchell leads work in the genomic evolution of human cancer and is based at the Wellcome Sanger Institute.
Department of Urology Cambridge University Hospitals